Literature DB >> 31935372

Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis.

Douglas Hanniford1, Alejandro Ulloa-Morales2, Alcida Karz2, Maria Gabriela Berzoti-Coelho3, Rana S Moubarak2, Beatriz Sánchez-Sendra4, Andreas Kloetgen2, Veronica Davalos5, Jochen Imig2, Pamela Wu6, Varshini Vasudevaraja7, Diana Argibay2, Karin Lilja8, Tommaso Tabaglio9, Carlos Monteagudo10, Ernesto Guccione11, Aristotelis Tsirigos12, Iman Osman13, Iannis Aifantis2, Eva Hernando14.   

Abstract

Metastasis is the primary cause of death of cancer patients. Dissecting mechanisms governing metastatic spread may uncover important tumor biology and/or yield promising therapeutic insights. Here, we investigated the role of circular RNAs (circRNA) in metastasis, using melanoma as a model aggressive tumor. We identified silencing of cerebellar degeneration-related 1 antisense (CDR1as), a regulator of miR-7, as a hallmark of melanoma progression. CDR1as depletion results from epigenetic silencing of LINC00632, its originating long non-coding RNA (lncRNA) and promotes invasion in vitro and metastasis in vivo through a miR-7-independent, IGF2BP3-mediated mechanism. Moreover, CDR1as levels reflect cellular states associated with distinct therapeutic responses. Our study reveals functional, prognostic, and predictive roles for CDR1as and expose circRNAs as key players in metastasis.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CDR1as; EZH2; GPX4; IGF2BP; LINC00632; PRC2; circRNA; melanoma; metastasis; miR-7

Mesh:

Substances:

Year:  2020        PMID: 31935372      PMCID: PMC7184928          DOI: 10.1016/j.ccell.2019.12.007

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  102 in total

1.  Ferroptosis: an iron-dependent form of nonapoptotic cell death.

Authors:  Scott J Dixon; Kathryn M Lemberg; Michael R Lamprecht; Rachid Skouta; Eleina M Zaitsev; Caroline E Gleason; Darpan N Patel; Andras J Bauer; Alexandra M Cantley; Wan Seok Yang; Barclay Morrison; Brent R Stockwell
Journal:  Cell       Date:  2012-05-25       Impact factor: 41.582

2.  A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors.

Authors:  David J Konieczkowski; Cory M Johannessen; Omar Abudayyeh; Jong Wook Kim; Zachary A Cooper; Adriano Piris; Dennie T Frederick; Michal Barzily-Rokni; Ravid Straussman; Rizwan Haq; David E Fisher; Jill P Mesirov; William C Hahn; Keith T Flaherty; Jennifer A Wargo; Pablo Tamayo; Levi A Garraway
Journal:  Cancer Discov       Date:  2014-04-25       Impact factor: 39.397

3.  Regulation of ferroptotic cancer cell death by GPX4.

Authors:  Wan Seok Yang; Rohitha SriRamaratnam; Matthew E Welsch; Kenichi Shimada; Rachid Skouta; Vasanthi S Viswanathan; Jaime H Cheah; Paul A Clemons; Alykhan F Shamji; Clary B Clish; Lewis M Brown; Albert W Girotti; Virginia W Cornish; Stuart L Schreiber; Brent R Stockwell
Journal:  Cell       Date:  2014-01-16       Impact factor: 41.582

4.  IMP3 RNP safe houses prevent miRNA-directed HMGA2 mRNA decay in cancer and development.

Authors:  Lars Jønson; Jan Christiansen; Thomas V O Hansen; Jonas Vikeså; Yohei Yamamoto; Finn C Nielsen
Journal:  Cell Rep       Date:  2014-04-03       Impact factor: 9.423

5.  MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression.

Authors:  Xiangjun Kong; Gaopeng Li; Yan Yuan; Yan He; Xiaoli Wu; Weijie Zhang; Zhengsheng Wu; Tingting Chen; Wenyong Wu; Peter E Lobie; Tao Zhu
Journal:  PLoS One       Date:  2012-08-02       Impact factor: 3.240

6.  Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans.

Authors:  Lesca M Holdt; Anika Stahringer; Kristina Sass; Garwin Pichler; Nils A Kulak; Wolfgang Wilfert; Alexander Kohlmaier; Andreas Herbst; Bernd H Northoff; Alexandros Nicolaou; Gabor Gäbel; Frank Beutner; Markus Scholz; Joachim Thiery; Kiran Musunuru; Knut Krohn; Matthias Mann; Daniel Teupser
Journal:  Nat Commun       Date:  2016-08-19       Impact factor: 14.919

7.  POSTAR: a platform for exploring post-transcriptional regulation coordinated by RNA-binding proteins.

Authors:  Boqin Hu; Yu-Cheng T Yang; Yiming Huang; Yumin Zhu; Zhi John Lu
Journal:  Nucleic Acids Res       Date:  2016-10-05       Impact factor: 16.971

8.  An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation.

Authors:  George P Souroullas; William R Jeck; Joel S Parker; Jeremy M Simon; Jie-Yu Liu; Joshiawa Paulk; Jessie Xiong; Kelly S Clark; Yuri Fedoriw; Jun Qi; Christin E Burd; James E Bradner; Norman E Sharpless
Journal:  Nat Med       Date:  2016-05-02       Impact factor: 53.440

9.  CircRNA-protein complexes: IMP3 protein component defines subfamily of circRNPs.

Authors:  Tim Schneider; Lee-Hsueh Hung; Silke Schreiner; Stefan Starke; Heinrich Eckhof; Oliver Rossbach; Stefan Reich; Jan Medenbach; Albrecht Bindereif
Journal:  Sci Rep       Date:  2016-08-11       Impact factor: 4.379

10.  A length-dependent evolutionarily conserved pathway controls nuclear export of circular RNAs.

Authors:  Chuan Huang; Dongming Liang; Deirdre C Tatomer; Jeremy E Wilusz
Journal:  Genes Dev       Date:  2018-05-17       Impact factor: 11.361

View more
  84 in total

1.  Genomic amplification of long noncoding RNA HOTAIRM1 drives anaplastic thyroid cancer progression via repressing miR-144 biogenesis.

Authors:  Ling Zhang; Jin Zhang; Shujing Li; Yanyan Zhang; Yun Liu; Jian Dong; Wenjun Zhao; Bo Yu; Huifang Wang; Jing Liu
Journal:  RNA Biol       Date:  2020-09-20       Impact factor: 4.652

Review 2.  The emerging roles of circular RNAs in regulating the fate of stem cells.

Authors:  Ziyao Zhuang; Lingfei Jia; Weiran Li; Yunfei Zheng
Journal:  Mol Cell Biochem       Date:  2020-09-11       Impact factor: 3.396

3.  The Use of circRNAs as Biomarkers of Cancer.

Authors:  Carla Solé; Gartze Mentxaka; Charles H Lawrie
Journal:  Methods Mol Biol       Date:  2021

4.  CircURI1 interacts with hnRNPM to inhibit metastasis by modulating alternative splicing in gastric cancer.

Authors:  Xiaolin Wang; Jingxin Li; Xing Bian; Cheng Wu; Jinghan Hua; Shuhui Chang; Tianyi Yu; Hong Li; Yongxiang Li; Shanshan Hu; Ge Shan; Wenchu Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-17       Impact factor: 11.205

Review 5.  RNA in cancer.

Authors:  Gregory J Goodall; Vihandha O Wickramasinghe
Journal:  Nat Rev Cancer       Date:  2020-10-20       Impact factor: 60.716

6.  Circular RNA circSMARCA5 is a prognostic biomarker in patients with malignant tumor: a meta-analysis.

Authors:  Fan Chao; Shiyu Wang; Cong Zhang; Dunsheng Han; Zhe Ma; Gang Chen
Journal:  BMC Cancer       Date:  2021-05-25       Impact factor: 4.430

Review 7.  Circular RNAs: new biomarkers of chemoresistance in cancer.

Authors:  Jiaqi Wang; Yi Zhang; Lianyu Liu; Ting Yang; Jun Song
Journal:  Cancer Biol Med       Date:  2021-03-19       Impact factor: 4.248

8.  TV-circRGPD6 Nanoparticle Suppresses Breast Cancer Stem Cell-Mediated Metastasis via the miR-26b/YAF2 Axis.

Authors:  Xiaoti Lin; Weiyu Chen; Fengqin Wei; Xiaoming Xie
Journal:  Mol Ther       Date:  2020-09-05       Impact factor: 11.454

9.  A Circle RNA Regulatory Axis Promotes Lung Squamous Metastasis via CDR1-Mediated Regulation of Golgi Trafficking.

Authors:  Emily B Harrison; Alessandro Porrello; Brittany M Bowman; Adam R Belanger; Gabriella Yacovone; Salma H Azam; Ian A Windham; Subrata K Ghosh; Menglin Wang; Nicholas Mckenzie; Trent A Waugh; Amanda E D Van Swearingen; Stephanie M Cohen; Devon G Allen; Tyler J Goodwin; Teresa Mascenik; James E Bear; Sarah Cohen; Scott H Randell; Pierre P Massion; Michael B Major; Leaf Huang; Chad V Pecot
Journal:  Cancer Res       Date:  2020-09-25       Impact factor: 12.701

Review 10.  Squaring the circle: circRNAs in melanoma.

Authors:  Nicol Mecozzi; Olga Vera; Florian A Karreth
Journal:  Oncogene       Date:  2021-07-30       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.